CLINICAL_TRIALS trial_result · 2024-06-04

Clinical Trial Update: A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration [Phase 3]

Summary

Phase 3 study evaluating the effects of brolucizumab in adults with neovascular age-related macular degeneration has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Neovascular Age Related Macular Degeneration | Phase 3 | Status: COMPLETED | Results posted: 2024-06-04